Head-To-Head Review: OrthoPediatrics and Edap Tms

Comparing the medical device companies' performance and investment potential

Published on Feb. 14, 2026

OrthoPediatrics (NASDAQ:KIDS) and Edap Tms (NASDAQ:EDAP) are both small-cap medical device companies, but which one is the better investment? The article compares the two companies across factors like profitability, institutional ownership, valuation, and analyst recommendations to determine which stock is more favorable.

Why it matters

This comparison is relevant for investors looking to allocate capital in the medical device sector, particularly for companies focused on pediatric and urology-related products and treatments. Understanding the relative strengths and weaknesses of OrthoPediatrics and Edap Tms can help inform investment decisions in this specialized area of the healthcare industry.

The details

The analysis finds that Edap Tms has higher earnings but lower revenue compared to OrthoPediatrics. However, OrthoPediatrics is trading at a lower price-to-earnings ratio, indicating it may be more affordable. Edap Tms has a higher potential upside based on analyst price targets, but OrthoPediatrics scores better on 10 out of 15 factors analyzed. Institutional ownership is also stronger for OrthoPediatrics.

  • The article was published on February 14, 2026.

The players

Edap Tms

A small-cap medical device company that develops, produces, and markets minimally invasive medical devices for urological diseases.

OrthoPediatrics

A medical device company that designs, develops, and markets anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions.

Got photos? Submit your photos here. ›

The takeaway

This head-to-head review highlights the relative strengths and weaknesses of two specialized medical device companies, Edap Tms and OrthoPediatrics, providing investors with insights to evaluate which stock may be the better investment opportunity in the pediatric and urology-focused healthcare sector.